DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $237,732 | -37.3% | 943 | -34.0% | 0.11% | -25.2% |
Q4 2022 | $379,130 | +63.4% | 1,428 | +58.7% | 0.15% | +10.5% |
Q3 2022 | $232,000 | -10.4% | 900 | -12.0% | 0.13% | -7.6% |
Q2 2022 | $259,000 | -44.1% | 1,023 | -35.2% | 0.14% | +4.3% |
Q1 2022 | $463,000 | -22.4% | 1,578 | -13.1% | 0.14% | -13.2% |
Q4 2021 | $597,000 | +18.0% | 1,816 | +9.3% | 0.16% | +43.2% |
Q3 2021 | $506,000 | +32.8% | 1,662 | +17.2% | 0.11% | +54.2% |
Q2 2021 | $381,000 | +14.1% | 1,418 | -4.5% | 0.07% | +10.8% |
Q1 2021 | $334,000 | +8.1% | 1,485 | +6.8% | 0.06% | +18.2% |
Q4 2020 | $309,000 | -10.2% | 1,391 | -13.0% | 0.06% | -22.5% |
Q3 2020 | $344,000 | +32.8% | 1,599 | +9.4% | 0.07% | +26.8% |
Q2 2020 | $259,000 | -12.5% | 1,462 | -24.2% | 0.06% | -5.1% |
Q4 2019 | $296,000 | -41.5% | 1,928 | -45.0% | 0.06% | -47.3% |
Q3 2019 | $506,000 | +10.5% | 3,504 | +9.3% | 0.11% | -13.2% |
Q2 2019 | $458,000 | +301.8% | 3,205 | +178.9% | 0.13% | +344.8% |
Q4 2017 | $114,000 | – | 1,149 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |